Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

HKSE 2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Gross Profit for the year ending December 31, 2023: USD 2.77 B

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Gross Profit is USD 2.77 B for the year ending December 31, 2023, a -7.94% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Gross Profit for the year ending December 31, 2022 was USD 3.01 B, a 1.91% change year over year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Gross Profit for the year ending December 31, 2021 was USD 2.96 B, a 14.30% change year over year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Gross Profit for the year ending December 31, 2020 was USD 2.59 B, a 5.65% change year over year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Gross Profit for the year ending December 31, 2019 was USD 2.45 B, a 15.65% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Loading...
HKSE: 2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

CEO Mr. Deyong Wen
IPO Date Oct. 30, 2012
Location China
Headquarters Building A
Employees 40,370
Sector Health Care
Industries
Description

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Similar companies

2607.HK

Shanghai Pharmaceuticals Holding Co., Ltd

USD 1.58

1.46%

1099.HK

Sinopharm Group Co. Ltd.

USD 2.59

1.33%

1177.HK

Sino Biopharmaceutical Limited

USD 0.37

1.03%

2269.HK

WuXi Biologics (Cayman) Inc.

USD 2.26

4.12%

StockViz Staff

January 15, 2025

Any question? Send us an email